announced today that it has completed patient enrollment in its Phase 2 clinical trial for Purified Exosome Product™ (PEP™) in the treatment of Diabetic Foot Ulcers (DFUs). This milestone ...

Diabetic foot problems are common throughout the world, and result in major medical, social and economic consequences for the patients, their families, and society. Foot ulcers are likely to be of ...

However, the effect of mesenchymal stem cells or their exosomes on macrophage efferocytosis of dying heart-muscle cells—in animal models with or without diabetes—has not been studied, Krishnamurthy ...